"Health insurance payers, providers, and pharma companies are expected to adopt blockchain systems ahead of other healthcare industry stakeholders," said Kamaljit Behera, Senior Industry Analyst, Transformational Health. "In the future, distributed ledger technology (DLT) will be leveraged by telehealth vendors and tech giants such as Apple, Amazon, Google, and Microsoft to monetize data science and analytical services with innovative patient-centric care models."
Frost & Sullivan's recent analysis, Global Blockchain Technology Market in the Healthcare Industry, 2018–2022, examines key growth opportunities and highlights key success factors and strategic imperatives for blockchain commercial deployment consideration in the healthcare space by assessing commercial partnerships. It also analyzes best-practice case studies for the identified growth opportunities.
For further information on this analysis, please visit: http://frost.ly/3w3.
In an emerging marketplace, the most successful blockchain technology providers will be those that:
- Explore applications like healthcare data infrastructure, health data access, on-demand healthcare, pharma drug supply chain, and identity management.
- Become a part of prominent consortiums such as synoptic, Hashed Health (Professional Credential Exchange), Insureum, and MediBloc among others.
- Engage with healthcare buyers as they undertake a thorough assessment of vendor solutions to invest in or engage with the most promising options.
- Target the United States market with payer- and provider-focused blockchain applications and countries such as Estonia, the United Kingdom, Switzerland, and South Korea with Blockchain-based PHR and patient identity applications.
- Establish a collaborative ecosystem for exploring and developing focused use cases and governance standards for future commercial scalability and success.
- The large-scale commercial deployment of PHR application seems more feasible in Europe and Asia where the healthcare data vendor ecosystem is relatively less complex compared to the US market.
- The interplay between three emerging technologies, namely Blockchain, Artificial Intelligence and IoT, will further catalyze the space of innovation adoption and related applications in the healthcare realm.
Global Blockchain Technology Market in the Healthcare Industry, 2018–2022 is part of Frost & Sullivan's global Life Sciences Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
http://ww2.frost.com
http://www.frost.com
SOURCE Frost & Sullivan
Frost & Sullivan's recent analysis, Global Blockchain Technology Market in the Healthcare Industry, 2018–2022, examines key growth opportunities and highlights key success factors and strategic imperatives for blockchain commercial deployment consideration in the healthcare space by assessing commercial partnerships. It also analyzes best-practice case studies for the identified growth opportunities.
For further information on this analysis, please visit: http://frost.ly/3w3.
In an emerging marketplace, the most successful blockchain technology providers will be those that:
- Explore applications like healthcare data infrastructure, health data access, on-demand healthcare, pharma drug supply chain, and identity management.
- Become a part of prominent consortiums such as synoptic, Hashed Health (Professional Credential Exchange), Insureum, and MediBloc among others.
- Engage with healthcare buyers as they undertake a thorough assessment of vendor solutions to invest in or engage with the most promising options.
- Target the United States market with payer- and provider-focused blockchain applications and countries such as Estonia, the United Kingdom, Switzerland, and South Korea with Blockchain-based PHR and patient identity applications.
- Establish a collaborative ecosystem for exploring and developing focused use cases and governance standards for future commercial scalability and success.
- The large-scale commercial deployment of PHR application seems more feasible in Europe and Asia where the healthcare data vendor ecosystem is relatively less complex compared to the US market.
- The interplay between three emerging technologies, namely Blockchain, Artificial Intelligence and IoT, will further catalyze the space of innovation adoption and related applications in the healthcare realm.
Global Blockchain Technology Market in the Healthcare Industry, 2018–2022 is part of Frost & Sullivan's global Life Sciences Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
http://ww2.frost.com
http://www.frost.com
SOURCE Frost & Sullivan
Chaineum : ICO, STO & IPO Boutique | Conseil Blockchain
Leloup Partners : Healthcare Investment Banking, Banque d'affaires des HealthTech
Leloup Partners : Healthcare Investment Banking, Banque d'affaires des HealthTech
No Offer, Solicitation, Investment Advice, or Recommendations
This website is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by FINYEAR.
No reference to any specific security constitutes a recommendation to buy, sell or hold that security or any other security.
Nothing on this website shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction.
Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this website, we have not taken into account the investment needs, objectives and financial circumstances of any particular investor.
This information has no regard to the specific investment objectives, financial situation and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors.
Any views expressed on this website by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change.
All information is subject to possible correction. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances.
No reference to any specific security constitutes a recommendation to buy, sell or hold that security or any other security.
Nothing on this website shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction.
Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this website, we have not taken into account the investment needs, objectives and financial circumstances of any particular investor.
This information has no regard to the specific investment objectives, financial situation and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors.
Any views expressed on this website by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change.
All information is subject to possible correction. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances.
Autres articles
-
Tether investit dans StablR pour promouvoir l'adoption du stablecoin en Europe
-
Chainalysis acquiert Hexagate, fournisseur de solutions de sécurité WEB3
-
Sia Partners ouvre "un peu" son capital à Blackstone.
-
IPEM 2025 - "New Promises for Private Markets" - du 28 au 30 janvier 2025 à Cannes
-
Coinbase & Chainlink, l'union autour du projet Diamond pour renforcer l'interopérabilité entre blockchains